Dova Pharmaceuticals rakes in about $75.1 mln after pricing IPO

By Iris Dorbian — 4 weeks ago

Durham, North Carolina-based Dova Pharmaceuticals, which is focused on buying, developing and commercializing drug candidates for rare diseases, raised about $75.1 million after pricing its over 4.41 million shares at $17 per share. The stock began trading June 29, 2017 on the NASDAQ under the ticker symbol “DOVA.” J.P. Morgan Securities LLC, Jefferies LLC and Leerink Partners were the underwriters. Dova’s backers included PBM Capital Investments and Perceptive Life Sciences.

Continue

Blue Apron shares make bland debut: Reuters

By Reuters News — 4 weeks ago

Blue Apron Holdings Inc‘s (APRN.N) shares were up about 1 percent in their market debut on Thursday following the meal-kit delivery company’s watered down IPO in the shadow of Amazon.com‘s (AMZN.O) deal to buy Whole Foods Market, Reuters reported.

Continue

Tintri pulls its IPO plans the night before its debut

By Alastair Goldfisher — 4 weeks ago

Mountain View, California-based Tintri Inc, a provider of storage management solutions, pulled its IPO the night before its schedule debut on the Nasdaq exchange. The company was planning to raise $109 million in the offering by selling 8.7 million shares between $10.50 and $12.50 per share. Tintri had raised more than $260 million in funding from such backers as Lightspeed Venture Partners, New Enterprise Associates, Menlo Ventures, Insight Venture Partners and Silver Lake Kraftwerk.

Continue

VC-backed Mersana Therapeutics debuts IPO

By Iris Dorbian — 4 weeks ago

Cambridge, Massachusetts-based biotech company Mersana Therapeutics has raised $75 million for its IPO after pricing its 5 million shares at $15 per share. The stock began trading June 28, 2017 on the NASDAQ under the ticker symbol “MRSN.” JP Morgan, Cowen and Leerink Partners are the lead underwriters. Mersana’s backers included Cormorant Asset Management, Arrowpoint Partners, Takeda Pharmaceutical Company Limited, New Enterprise Associates and Rock Springs Capital.

Continue

PE-backed Vencore files to go public

By Iris Dorbian — 1 month ago

Chantilly, Virginia-based Vencore, a provider of information solutions, engineering and analytics for the U.S. government, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. Goldman Sachs and Wells Fargo Securities are serving as the lead underwriters. Vencore is a portfolio company of Veritas Capital.

Continue